Molecular genetics of Wiedemann-Beckwith syndrome

American Journal of Medical Genetics

Volumn 79, Issue 4, 1998, Pages 253-259

  Li, Madeline ^a   Squire, Jeremy A ^b   Weksberg, Rosanna ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Genomic imprinting; IGF2; Overgrowth syndromes; p57(KIP2); Wiedemann Beckwith syndrome

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; BECKWITH WIEDEMANN SYNDROME; CHROMOSOME 11P; CONFERENCE PAPER; GENETIC DISORDER; GENOME IMPRINTING; GROWTH DISORDER; GROWTH REGULATION; MULTIPLE MALFORMATION SYNDROME; NONHUMAN; PRIORITY JOURNAL;

BECKWITH-WIEDEMANN SYNDROME; HUMANS; MOLECULAR BIOLOGY;

ANIMALIA;

EID: 0032475940     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19981002)79:4<253::AID-AJMG5>3.0.CO;2-N     Document Type: Conference Paper

References (76)

1. Baylin SB (1997): Tying it all together: Epigenetics, genetics, cell cycle, and cancer. Science 277:1948-1949.
2. Beckwith J (1969): Macroglossia, omphalocele, adrenal cytomegaly, gigantism, and hyperplastic visceromegaly. Birth Defects: Original Articles Series 5:188-196.
3. Berry AC, Belton EM, Chantler C (1980): Monozygotic twins discordant for Wiedemann-Beckwith syndrome and the implications for genetic counselling. J Med Genet 17:136-8.
4. Bird L, Naumova A, Feinberg A, Grundy P, Henry I, Junien C, Newsham I, Weksberg R, Sapienza C (1995): Skewed X-inactivation in sporadic Beckwith-Wiedemann patients. International Conference on Molecular and Clinical Genetics of Childhood Renal Tumors, Philadelphia, PA.
5. Brown KW, Villar AJ, Bickmore W, Clayton-Smith J, Catchpoole D, Maher ER, Reik W (1996): Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway. Hum Mol Genet 5:2027-2032.
6. Buiting K, Saitoh S, Gross S, Dittrich B, Schwartz S, Nicholls R, Horsthemke B (1995): Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nat Genet 9:395-400.
7. Carlin M, Escobar L, Ward R, Wielgus T (1990): A reassessment of Beckwith-Wiedemann syndrome (WBS). Am J Hum Genet 47 (Suppl):A50.
8. Coppes MJ, Bonetta L, Huang A, Hoban P, Chilton-MacNeill S, Campbell CE, Weksberg R, Yeger H, Reeve AE, Williams BR (1992): Loss of heterozygosity mapping in Wilms' tumor indicates the involvement of three distinct regions and a limited role for non-dysjunction or mitotic recombination. Genes Chromosomes Cancer 5:326-334.
9. DeChiara TM, Efstratiadis A, Robertson EJ (1990): A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345:78-80.
10. Dittrich B, Buiting K, Korn B, Rickard S, Buxton J, Saitoh S, Nicholls RD, Poustka A, Winterpacht A, Zabel B, Horsthemke B (1996): Imprint switching on human chromosome 15 may involve alternative transcripts of the SNRPN gene [see comments]. Nat Genet 14:163-170.
11. Douc-Rasy S, Barrois M, Fogel S, Ahomadegbe JC, Stehelin D, Coll J, Riou G (1996): High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas: Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Oncogene 12:423-430.
12. Eggenschwiler J, Ludwig T, Fisher P, Leighton PA, Tilghman SM, Efstratiadis A (1997): Mouse mutant embryos overexpressing IF-11 exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes Dev 11:3128-3142.
13. Ekstrom TJ (1994): Parental imprinting and the IGF2 gene. Horm Res 42:176-181.
14. Elson DA, Bartolomei MS (1997): A 5′ differentially methylated sequence and the 3' flanking region are necessary for H19 transgene imprinting. Mol Cell Biol 17:309-317.
15. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B (1993): Tumor-suppressor activity of H19 RNA. Nature 365:764-767.
16. Hashimoto K, Azuma C, Koyama M, Ohashi K, Kamiura S, Nobunaga T, Kimura T, Tokugawa Y, Kanai T, Saji F (1995): Loss of imprinting in choriocarcinoma [letter]. Nat Genet 9:109-110.
17. KIP2 is mutated in Beckwith-Wiedemann syndrome [see comments], Nat Genet 14:171-173.
18. KIP2 mutations in Wiedemann-Beckwith syndrome. Hum Genet 100:681-683.
19. Henry I, Jeanpierre M, Barichard F, Serre JL, Mallet J, Turleau C, de Grouchy J, Junien C (1988): Duplication of HRAS1, INS, and IGF2 is not a common event in Beckwith-Wiedemann syndrome. Ann Genet 31:216-220.
20. Henry I, Bonaiti-Pellie C, Chehensse V, Beldjord C, Schwartz C, Utermann G, Junien C (1991): Uniparental paternal disomy in a genetic cancer-predisposion syndrome. Nature 351:665-667.
21. Herzing L, Romer J, Horn J, Ashworth A (1997): Xist has properties of the X-chromosome inactivation centre. Nat Genet 386:272-275.
22. Hoovers JMN, Kalikin LM, Johnson LA, Alders M, Redeker B, Law DJ, Bliek J, Steenman M, Benedict M, Wiegant J, Lengauer C, Taillon-Miller P, Schlessinger D, Edwards MC, Elledge SJ, Ivens A, Westerveld A, Little P, Mannens M, Feinberg AP (1995): Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragments. Proc Natl Acad Sci USA 92:12456-12460.
23. Knudson AG, Strong LC (1972): Mutation and cancer: A model for Wilms' tumor of the kidney. J Natl Cancer Inst 48:313-324.
24. Koufos A, Grundy P, Morgan K, Aleck KA, Hadro T, Lampkin BC, Kalbakji A, Cavenee WK (1989): Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am J Hum Genet 44:711-719.
25. Lau MM, Stewart CE, Liu Z, Bhatt H, Rotwein P, Stewart CL (1994): Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 8: 2953-2963.
26. Lee J, Jaenisch R (1997): Long-range cis effects of ectopic X-inactivation centres on a mouse autosome. Nat Genet 386:275-279.
27. KIP2 mutation in Beckwith-Wiedemann syndrome. Am J Hum Genet 61:304-309.
28. Lee MP, Hu RJ, Johnson LA, Feinberg AP (1997b): Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements. Nat Genet 15: 181-185.
29. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM (1995a): Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375:34-39.
30. Leighton PA, Saam JR, Ingram RS, Stewart CL, Tilghman SM (1995b): An enhancer deletion affects both 1119 and IGF2 expression. Genes Dev 9:2079-2089.
31. Leonard NJ, Bernier FP, Rudd N, Machin GA, Bamforth F, Bamforth S, Grundy P, Johnson C (1996): Two pairs of male monozygotic twins discordant for Wiedemann-Beckwith syndrome. Am J Med Genet 61: 253-257.
32. Li X, Adam G, Cui H, Sandstedt B, Ohlsson R, Ekstrom TJ (1995): Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: Uncoupling of IGF2 and H19 imprinting. Oncogene 11:221-229.
33. Li X, Cui H, Sandstedt B, Nordlinder H, Larsson E, Ekstrom TJ (1996): Expression levels of the insulin-like growth factor-II gene (IGF2) in the human liver: Developmental relationships of the four promoters. J Endocrinol 149:117-124.
34. Li X, Nong Z, Ekstrom C, Larsson E, Nordlinder H, Hofmann WJ, Trautwein C, Odenthal M, Dienes HP, Ekstrom TJ, Schirmacher P (1997): Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma. Cancer Res 57:2048-2054.
35. Litz CE, Taylor KA, Qiu JS, Pescovitz OH, de Martinville B (1988): Absence of detectable chromosomal and molecular abnormalities in monozygotic twins discordant for the Wiedemann-Beckwith syndrome. Am J Med Genet 30:821-833.
36. Lyko F, Brenton JD, Surani MA, Paro R (1997): An imprinting element from the mouse H19 locus functions as a silencer in Drosophila. Nat Genet 16:171-173.
37. Mannens M (1988): Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumors. Hum Genet 81:41-48.
38. KIP2, a structurally distinct member of the p21cip1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9:650-662.
39. Morison IM, Becroft DM, Taniguchi T, Woods CG, Reeve AE (1996): Somatic overgrowth associated with overexpression of insulin-like growth factor II. Nat Med 2:311-316.
40. Moutou C, Junien C, Henry I, Bonaïti-Pellié C (1992): Beckwith-Wiedemann syndrome: A demonstration of the mechanisms responsible for the excess of transmitting females [see comments]. J Med Genet 29:217-220.
41. Nakao M, Sasaki H (1996): Genomic imprinting: Significance in development and diseases and the molecular mechanisms. J Biochem 120:467-473.
42. Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, Faure S, Gary F, Coumel P, Petit C, Schwartz K, Guicheney P (1997): A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome [see comments]. Nat Genet 15:186-189.
43. Nicholls RD (1994): New insights reveal complex mechanisms involved in genomic imprinting [editorial; comment]. Am J Hum Genet 54:733-740.
44. Nystrom A, Cheetham JE, Engstrom W, Schofield PN (1992): Molecular analysis of patients with Wiedemann-Beckwith syndrome. II. Paternally derived disomies of chromosome 11. Eur J Pediatr 151:511-514.
45. Ogawa O, Becroft DM, Morison IM, Eccles MR, Skeen JE, Mauger DC, Reeve AE (1993): Constitutional relaxation of insulin-like growth factor II gene imprinting associated with Wilms' tumor and gigantism. Nat Genet 5:408-412.
46. Ohlsson R, Hedborg F, Holmgren L, Walsh C, Ekstrom TJ (1994): Overlapping patterns of IGF2 and H19 expression during human development: Biallelic IGF2 expression correlates with a lack of H19 expression. Development 120:361-368.
47. Okano YOY, Yamamoto H, Hase Y, Tsuruhara T, Fujita H (1986): An infant with Beckwith-Wiedemann syndrome and chromosomal duplication 11p13-pter: Correlation of symptoms between 11p trisomy and Beckwith-Wiedemann syndrome. Jpn J Hum Genet 31:365-372.
48. KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors. Am J Hum Genet 61:295-303.
49. Olney AH, Buehler BA, Waziri M (1988): Wiedemann-Beckwith syndrome in apparently discordant monozygotic twins. Am J Med Genet 29:491-499.
50. Orstavik RE, Tommerup N, Eiklid K, Orstavik KH (1995): Non-random X chromosome inactivation in an affected twin in a monozygotic twin pair discordant for Wiedemann-Beckwith syndrome. Am J Med Genet 56: 210-214.
51. Pettenati MJ, Haines JL, Higgins RR, Wappner RS, Palmer CG, Weaver DD (1986): Wiedemann-Beckwith syndrome: Presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Hum Genet 74:143-154.
52. Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, Neri G, Cao A, Forabosco A, Schlessinger D (1996): Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome [see comments]. Nat Genet 12:241-247.
53. Ping AJ, Reeve AE, Law DJ, Young MR, Boehnke M, Feinberg AP (1989): Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am J Hum Genet 44:720-723.
54. Rainier S, Dobry CJ, Feinberg AP (1995): Loss of imprinting in hepatoblastoma. Cancer Res 55:1836-1838.
55. Reik W, Maher ER (1997): Imprinting in clusters: Lessons from Beckwith-Wiedemann syndrome. Trends Genet 13:330-334.
56. Robison L (1997): General principles of the epidemiology of childhood cancer. In Pizzo PA, Poplack D (eds): "Principles and Practice of Pediatric Oncology." Philadelphia: Lippincott-Raven Publishers, pp 1-10.
57. Slavotinek A, Gaunt L, Donnai D (1997): Paternally inherited duplications of Ilpl5.5 and Beckwith-Wiedemann syndrome. J Med Genet 34:819-826.
58. Song HH, Shi W, Filmus J (1996): OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2. J Biol Chem 272:7574-7577.
59. Squire J, Weksberg R (1995): Genomic imprinting in tumors. In Squire J, Shear D (eds): "Gene Rearrangements and Cancer," Vol. 7. Seminars in Cancer Biology. New York: Academic Press, pp 41-47.
60. Sun FI, Dean WL, Kelsey G, Allen NA, Reik W (1997): Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. Nature 389:809-815.
61. Taniguchi T, Schofield AE, Scarlett JL, Morison IM, Sullivan MJ, Reeve AE (1995a): Altered specificity of IGF2 promoter imprinting during fetal development and onset of Wilms tumor. Oncogene 11:751-756.
62. Taniguchi T, Sullivan MJ, Ogawa O, Reeve AE (1995b): Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc Natl Acad Sci USA 92:2159-2163.
63. Thornburn M, Wright E, Miller C, Smith-Read E (1970): Exomphalosmacroglossia-gigantism syndrome in Jamaican infants. Am J Dis Child 119:316-321.
64. Uchida K, Kondo M, Takeda S, Osada H, Takahashi T, Nakao A, Takahashi T (1997): Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma. Mol Carcinog 18:193-198.
65. Vu TH, Hoffman A (1996): Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor. J Biol Chem 271:9014-9023.
66. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Toubin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT (1996): Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 12:17-23.
67. Weksberg R, Glaves M, Teshima I, Waziri M, Patil S, Williams BR (1990): Molecular characterization of Beckwith-Wiedemann syndrome (WBS) patients with partial duplication of chromosome lip excludes the gene MYOD1 from the WBS region. Genomics 8:693-698.
68. Weksberg R, Shen DR, Fei YL, Song QL, Squire J (1993a): Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat Genet 5:143-150.
69. Weksberg R, Teshima I, Williams BR, Greenberg CR, Pueschel SM, Chernos JE, Fowlow SB, Hoyme E, Anderson IJ, Whiteman DA (1993b): Molecular characterization of cytogenetic alterations associated with the Beckwith-Wiedemann syndrome (WBS) phenotype refines the localization and suggests the gene for WBS is imprinted. Hum Mol Genet 2:549-556.
70. Weksberg R, Squire JA (1996): Molecular biology of Beckwith-Wiedemann syndrome. Med Pediatr Oncol 27:462-469.
71. Wiedemann HR (1964): Complexe malformatif familial avec hernie ombilicale et macroglossie: Un syndrome nouveau? J Génét Hum 13:223-232.
72. Wiedemann HR (1983): Tumors and hemihypertrophy associated with the Wiedemann-Beckwith syndrome. Eur J Pediatr 141:129.
73. KIP2 results in increased apoptosis and delayed dif-ferentiation during mouse development. Genes Dev 11:973-983.
74. Zhan S, Shapiro DN, Helman LJ (1994): Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. J Clin Invest 94:445-448.
75. Zhan S, Shapiro DN, Helman LJ (1995): Loss of imprinting of IGF2 in Ewing's sarcoma. Oncogene 11:2503-2507.
76. KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387:151-158.